Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Newsletters
Newsletter Center
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
ABUS
Stock Latest News
Press Releases
Arbutus to Present at JMP Securities Life Sciences Conference
18d ago
ABUS
Press Releases
Arbutus Reports First Quarter 2023 Financial Results and Corporate Update
23d ago
ABUS
Pre-Earnings
Arbutus Biopharma (ABUS) Q1 Earnings Cheat Sheet
25d ago
ABUS
The Fly
Arbutus Biopharma announces clinical data for AB-729 trial
30d ago
ABUS
Press Releases
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data as Oral Presentations at the Global Hepatitis Summit 2023
1M ago
ABUS
Press Releases
Arbutus Announces FDA Clinical Hold on IND Application for AB-101, an oral PD-L1 inhibitor
1M ago
ABUS
The Fly
Arbutus Biopharma announces FDA clinical hold on IND for AB-101
1M ago
ABUS
Press Releases
Arbutus to Report First Quarter 2023 Financial Results and Provide Corporate Update
1M ago
ABUS
Press Releases
Arbutus to Present AB-729 and AB-161 Data at the Global Hepatitis Summit 2023
1M ago
ABUS
The Fly
Arbutus, Genevant file patent infringement suit against Pfizer, BioNTech
2M ago
PFE
ABUS
Press Releases
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech
2M ago
ABUS
The Fly
Arbutus Biopharma doses first subject in Phase 1 trial with AB-161
2M ago
ABUS
Press Releases
Arbutus Doses First Subject in Phase 1 Clinical Trial with its Oral RNA Destabilizer, AB-161
2M ago
ABUS
Press Releases
Arbutus Presents AB-343 Data at the 36th International Conference on Antiviral Research
2M ago
ABUS
Press Releases
Arbutus Reports Fourth Quarter and Year End 2022 Financial Results and Corporate Update
3M ago
ABUS
The Fly
Arbutus Biopharma reports FY22 EPS (46c), consensus (45c)
3M ago
ABUS
The Fly
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
3M ago
ABUS
ALNY
The Fly
SVB downgrades Moderna to Underperform as COVID boom reverses
3M ago
ABUS
ALNY
Press Releases
Arbutus to Report Fourth Quarter and Year End 2022 Financial Results and Provide Corporate Update
3M ago
ABUS
The Fly
Arbutus Biopharma management to meet with Piper Sandler
3M ago
ABUS
The Fly
Arbutus Biopharma management to meet with Piper Sandler
3M ago
ABUS
Press Releases
Arbutus to Participate in Three Upcoming Investor Conferences
4M ago
ABUS
Show More
You need to enable JavaScript to run this app.
